Insider Transactions in Q4 2020 at Galera Therapeutics, Inc. (GRTX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 13
2020
|
Lawrence M Alleva |
BUY
Open market or private purchase
|
Direct |
2,325
+26.88%
|
$23,250
$10.22 P/Share
|
|
Nov 13
2020
|
Joel F. Sussman Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$100,000
$10.32 P/Share
|
|
Nov 13
2020
|
Joel F. Sussman Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+34.89%
|
$10,000
$1.55 P/Share
|
|
Nov 12
2020
|
Joel F. Sussman Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$100,000
$10.06 P/Share
|
|
Nov 12
2020
|
Joel F. Sussman Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$10,000
$1.07 P/Share
|
|
Oct 26
2020
|
Jon T Holmlund Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,244
-100.0%
|
$33,660
$15.0 P/Share
|
|
Oct 26
2020
|
Jon T Holmlund Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,244
+50.0%
|
$4,488
$2.43 P/Share
|
|
Oct 15
2020
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
450,000
-13.2%
|
$4,950,000
$11.0 P/Share
|
|
Oct 06
2020
|
Jon T Holmlund Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,536
-100.0%
|
$126,432
$12.0 P/Share
|
|
Oct 06
2020
|
Jon T Holmlund Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,536
+50.0%
|
$10,536
$1.11 P/Share
|
|
Oct 05
2020
|
Jon T Holmlund Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
100
-100.0%
|
$1,200
$12.0 P/Share
|
|
Oct 05
2020
|
Jon T Holmlund Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+50.0%
|
$100
$1.07 P/Share
|